local_hospital

Azienda Socio Sanitaria Territoriale Ovest Milanese

Address
lock Available on a paid plan

Oncology and Hematologic Malignancies

The research portfolio at Azienda Socio Sanitaria Territoriale Ovest Milanese includes a strong focus on neoplasms and blood cancers, especially multiple myeloma, lung cancer, breast cancer, colorectal cancer, urothelial carcinoma, and follicular lymphoma. These studies are designed to evaluate new treatment options, compare them with current standards, and improve outcomes for people with advanced or relapsed disease.

  • Testing new therapies and combinations for relapsed or refractory multiple myeloma
  • Evaluating treatment effectiveness in non-small cell lung cancer and small cell lung cancer
  • Comparing newer approaches for breast cancer, colorectal cancer, and urothelial carcinoma
  • Refining care strategies for follicular lymphoma and other hematologic malignancies

Overall, this site is active in studies that aim to improve survival, disease control, and treatment choice across several major cancer types.

Gastroenterology and Immune-Mediated Disease

Another major area of research covers digestive system diseases and immune system diseases, with trials in ulcerative colitis and Crohn's disease. These studies are focused on understanding how well new therapies work in inflammatory bowel disease and whether they can help patients achieve and maintain remission.

  • Assessing new treatment options for moderately to severely active ulcerative colitis
  • Studying induction and maintenance strategies in Crohn's disease
  • Evaluating whether emerging therapies can improve symptom control and long-term disease management
  • Supporting better care for patients with chronic inflammatory conditions of the bowel

These trials reflect a clear interest in improving both short-term response and ongoing disease control in immune-driven gastrointestinal disorders.

Cardiovascular and Surgical Research

The site also contributes to research in cardiovascular diseases and surgical procedures, including studies related to aortic stenosis, mitral valve surgery, and postoperative low-cardiac output syndrome. This work aims to improve procedural safety, support recovery, and optimize outcomes around major heart interventions.

  • Evaluating supportive approaches during transcatheter aortic valve replacement
  • Studying ways to reduce complications after mitral valve surgery
  • Testing strategies to lower the risk of low-cardiac output syndrome
  • Improving perioperative care in complex cardiovascular procedures

At this hospital and clinic setting, these trials are centered on making advanced cardiac and surgical care safer and more effective.

Kidney, Diagnostic, and Supportive Care Studies

Research at the site also spans hemic and lymphatic diseases, anesthesia and analgesia, and broader health care quality topics, with additional attention to non-diabetic chronic kidney disease and diagnostic refinement in cancer care. These studies explore whether new approaches can slow kidney disease progression, improve treatment selection, and support better patient management.

  • Testing therapies aimed at slowing progression in non-diabetic chronic kidney disease
  • Exploring diagnostic tools and biomarkers to guide cancer treatment decisions
  • Assessing supportive and perioperative care approaches that may improve patient comfort and safety
  • Strengthening the quality and effectiveness of care delivered in a general surgery environment

This broad research activity shows the site’s interest in both treatment innovation and practical improvements in everyday clinical care.

Complex Abdominal Wall and Hernia Repair

Within general surgery, the site is involved in studies on complex hernia repair and abdominal wall reconstruction. The focus is on patients with challenging hernia anatomy, where researchers are evaluating methods that may improve surgical planning, tissue mobility, and overall repair outcomes.

  • Studying new approaches for large and complex abdominal hernias
  • Evaluating ways to improve abdominal wall reconstruction
  • Assessing whether pre-surgical interventions can support better operative results
  • Advancing practical techniques for difficult surgical cases

These trials highlight the site’s role in developing more effective solutions for patients with technically demanding surgical problems.

Site Overview

assignment
34
connected trials
corporate_fare
29
sponsors
science
70
IMPs

Activity Indicator

Last 6 months

4
Trials started
-56% vs previous period.
9
Trials started 6–12 months ago
34
Total trials linked
Highly Active
trending_downDeclining-56%
2
2
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 5 of 11 therapeutic areas and 15 of 70 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years

Top 40 of 67 compounds, ranked by number of trials.

lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
22
Sponsors (total)
29
Active sponsors
18

Sponsor Network

Top 18 by active trials.

lock +17 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +3 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 566 other sites in Italy

description
Trial volume
34
Outperforms 80% of sites
public
Therapeutic diversity
11areas
Outperforms 85% of sites
groups
Sponsor diversity
29sponsors
Outperforms 82% of sites

Therapeutic Area Benchmark — Italy

Select a therapeutic area to compare against other sites in Italy.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Italy

Market Share

Country: Italy

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Azienda Socio Sanitaria Territoriale Ovest Milanese

lock Showing 1 of 34 trials — the rest is available on a paid plan.

IMP list

lock Showing 1 of 70 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Dexamethasone6Unknown2022-02-022025-09-30

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.